May 12, 2024
Loading...
You are here:  Home  >  'Thousand Oaks'  -  Page 65
Latest

Amgen funds STEM program for Girl Scouts

By   /  Friday, February 3rd, 2017  /  Health Care & Life Science, Higher Education, Latest news, Nonprofits  /  Comments Off on Amgen funds STEM program for Girl Scouts

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen beats analyst estimates for fourth quarter revenue

By   /  Thursday, February 2nd, 2017  /  Earnings, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen beats analyst estimates for fourth quarter revenue

Thousand Oaks-based biotech giant Amgen reported revenue of $6 billion in the fourth quarter of 2016, besting analyst estimates of $5.74 billion and increasing 8 percent from the fourth quarter of 2015. The world’s largest biotech drug maker posted total revenues of $23 billion on the year, up 6 percent from 2015. Revenue gains were Read More →

Latest

Teledyne Technologies reports decline in net income

By   /  Thursday, February 2nd, 2017  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Teledyne Technologies reports decline in net income

Thousand-Oaks based Teledyne Technologies reported a drop in net income for its fiscal year 2016 over the prior year, with a 7 percent fourth quarter drop in sales to $552.9 million. Net income from continuing operations came to $192.9 million, or $5.43 per diluted share, compared to $198 million in 2015, while total sales fell Read More →

Latest

Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira

By   /  Friday, January 27th, 2017  /  Health Care & Life Science, Latest news, Technology  /  Comments Off on Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira

The European Medicines Agency recommended the approval of the ABP 501, a biosimilar of AbbVie’s Humira (adalimumab), for treatment of inflammatory diseases, Thousand Oaks-based biotech company Amgen announced on Jan. 27. The EMA recommended ABP 501’s use for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis, severe axial spondyloarthritis without radiographic evidence of AS, moderate-to-severe Read More →

Latest

New city manager focusing on Thousand Oaks Boulevard

By   /  Friday, January 20th, 2017  /  East Ventura County, Features, Latest news, Small Business, Tri-County Economy  /  Comments Off on New city manager focusing on Thousand Oaks Boulevard

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Sares-Regis buys 29 acres at Conejo Spectrum in Thousand Oaks

By   /  Monday, January 16th, 2017  /  Latest news, Real Estate  /  Comments Off on Sares-Regis buys 29 acres at Conejo Spectrum in Thousand Oaks

The Sares-Regis Group bought 29 acres of land at the Conejo Spectrum Business Park in Thousand Oaks with plans to build out industrial buildings, according to Colliers International. The property management company with an office in Goleta partnered with an investment firm to purchase the land near Rancho Conejo Boulevard and Conejo Spectrum Drive for Read More →

Latest

Here’s a wish list for leadership in 2017

By   /  Friday, January 13th, 2017  /  Latest news, Op/Eds  /  Comments Off on Here’s a wish list for leadership in 2017

By Ritch Eich America appears to be continuing down the same divided path that plagued our nation in 2016. We desperately need enlightened leadership in the New Year. Here is my Top 10 “Wish List” for elected officials and organizational leaders who are in positions to move our country forward. 1. Assemble world leadership: Focus Read More →